1)神谷茂:ディフィシル菌感染症の基礎と臨床.Mod Media 56:233-241,2010
2)中村信一:毒素産生菌感染症の基礎と臨床 ディフィシル菌感染症.毒素産生菌とその感染症(竹田美文,本田武司編),医薬ジャーナル社,pp120-132,1998
3)日本臨床微生物学会検査法マニュアル作成委員会・嫌気性菌検査ガイドライン委員会:嫌気性菌検査ガイドライン2012.日臨微生物誌 22(Suppl.1):1-142,2012
4)Kramer A, Schwebke I, Kampf G:How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130,2006
5)Debast SB, Bauer MP, Kuijper EJ, et al:European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20(Suppl 2):1-26,2014
6)Arango JI, Restrepo A, Schneider DL, et al:Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 37:517-521,2006
7)Kelly CP, LaMont JT:Clostridium difficile--more difficult than ever. N Engl J Med 359:1932-1940,2008
8)NCCLS:Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard M11-A5, Villanova, PA, NCCLS, 2001
9)EUCAST:Clinical breakpoint, bacteria v4.0(http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_4.0.pdf)
10)EUCAST:MIC distributions, Antimicrobial wild type distributions of microorganisms(http://mic.eucast.org/Eucast2/)
11)Guerrant RL, Van Gilder T, Steiner TS, et al:Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331-351,2001
12)西神戸医療センター感染対策マニュアル:CD発生時の対応マニュアル